Needham & Company LLC Reiterates Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)
otakuyassine3@gmail.com Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment...
Reiterates
Weiss Ratings Reiterates “Sell (E+)” Rating for 10x Genomics (NASDAQ:TXG)
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reiterated by...
Needham & Company LLC Reiterates “Buy” Rating for Veracyte (NASDAQ:VCYT)
Veracyte (NASDAQ:VCYT – Get Free Report)‘s stock had its “buy” rating reaffirmed by Needham &...
HC Wainwright Reiterates Buy Rating for Prothena (NASDAQ:PRTA)
Prothena (NASDAQ:PRTA – Get Free Report)‘s stock had its “buy” rating restated by equities researchers...
Royal Bank of Canada Reiterates “Outperform” Rating for Realty Income (NYSE:O)
Realty Income (NYSE:O – Get Free Report)‘s stock had its “outperform” rating restated by investment...
Stephens Reiterates Overweight Rating for Wingstop (NASDAQ:WING)
Wingstop (NASDAQ:WING – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts...
Wedbush Reiterates “Outperform” Rating for IDEAYA Biosciences (NASDAQ:IDYA)
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “outperform” rating restated by equities...